Scholars Central

ArticlePublished 15 Jan 2025

Personality Trait and Antidepressant Type are Potential Moderators of the Association between Genotypes of HTR1A-rs6295 or HTR2A-rs6311 with Treatment Response

Authors: Ibrahim Mohammed Badamasi, Munn Sann Lye, Normala Ibrahim, Nurul Asyikin Abdul Razaq, King Hwa Ling, Johnson Stanslas

Clinical Schizophrenia & Related Psychoses

Volume 19 · Issue 1 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Currently, empiric treatment of Major Depressive Disorder (MDD) relies on the characteristics of the presenting patients. Aim: The aim of the current study was to identify moderators for the association of SSRI treatment efficacy response phenotype with genotypes of HTR1A-rs6295 or HTR2A-rs6311 polymorphism in a population of MDD patients. Materials and methods: The study included 300 patients with MDD. The assessment of Selective Serotonin Reuptake Inhibitors (SSRI) treatment response was based on 50% reduction in the depressive score obtained within 6 weeks of treatment onset on the Montgomery Asberg Depression Rating Scale (MADRS-S) for each patient recruited in the psychiatric clinics of the four tertiary hospitals in the Klang valley region of Malaysia. Results: The study population was made up of young adults (median age=37.00 years), mostly females (67.1%) with no family history of psychiatric illness (73.4%). MDD patients with the GA genotype for the HTR2A-rs6311 polymorphism and received escitalopram antidepressant were significantly (over-dominant model; P=0.019, OR=0.114 (0.019–0.701)) less likely to respond to treatment. The CG+GG genotype of HTR1A-rs6295 gene polymorphism was associated with significantly (recessive model: P=0.019, OR=0.146 (0.026-0.733)) reduced likelihood of responding to antidepressant treatment among the MDD patients with the irritability personality trait. Conclusion: The association between the CG genotype of the HTR1A-rs6295 with poor SSRI treatment response is elaborated among patients that have an irritable personality. The role of medication type in determining the direction of association between genotype of the HTR2Ars6311 with treatment response identified in the literature was also revalidated in the current study.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Schizophrenia & Related Psychoses.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Schizophrenia & Related Psychoses
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Ibrahim Mohammed Badamasi”
  • BylineArticles whose byline prints “Munn Sann Lye”
  • BylineArticles whose byline prints “Normala Ibrahim”
  • BylineArticles whose byline prints “Nurul Asyikin Abdul Razaq”
  • BylineArticles whose byline prints “King Hwa Ling”
  • BylineArticles whose byline prints “Johnson Stanslas”